Optimizing Quality of Life by Improved Patient Expectation Following Atrial Fibrillation Catheter Ablation
Recruiting · NCT05557526 · Interventional (participants receive a specific treatment) · Lead sponsor: Evangelical Hospital Düsseldorf
View the official record on ClinicalTrials.gov →Interventions studied
Expectation optimization
What this trial is about
The aim is to investigate whether optimizing patients' expectations towards the interventional treatment of atrial fibrillation (catheter ablation) leads to a lower disease-related impairment of the patients compared to the control group in the first three months after ablation (the so-called blanking period).
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- symptomatic atrial fibrillation
- indication for pulmonary vein isolation
- sufficient command of the German language
Exclusion criteria
- age \<18 years
- permanent atrial fibrillation
- presence of psychiatric disorders which impair the study participitatin
- presence of another medical condiction which influences quality of life stronger than the cardiac condition
- atrial fibrillation induced by intoxication, medicamentation or infection
- inability to grap the course of the study
Where it is running
2 locations listed.
- Westdeutsches Herz- und Gefäßzentrum - Essen, Germany
- Evangelic Hospital Düsseldorf - Düsseldorf, North Rhine-Westfalia, Germany